JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web browser. It makes web pages functional for specific purposes and if disabled for some reason, the content or the functionality of the web page can be limited or unavailable.

Saturday, March 8, 2025

John E Sabga Foundation sets up

Pancreatic cancer clinical trial for T&T

by

CHARLES KONG SOO
2206 days ago
20190217

CHARLES KONG SOO

Pan­cre­at­ic can­cer has the high­est mor­tal­i­ty rate of all can­cers be­cause of the mere fact that it shows no signs or symp­toms un­til it reach­es stage four. Ac­cord­ing to the Amer­i­can Can­cer So­ci­ety, for all stages com­bined, the one-year rel­a­tive sur­vival rate is 20 per cent and the five-year rate is sev­en per cent.

The John E Sab­ga Foun­da­tion (JESF) for Pan­cre­at­ic Can­cer through its part­ner­ship with world-renowned pan­cre­at­ic can­cer ex­pert Dr Daniel Von Hoff and the Trans­la­tion­al Ge­nomics Re­search In­sti­tute (TGen) in Phoenix, Ari­zona, are work­ing to­wards con­duct­ing the first of its kind clin­i­cal tri­al in T&T in hopes of com­ing clos­er to a cure for the dread­ed dis­ease.

JESF founder Na­tal­ie Sab­ga said “We have al­ready got­ten ap­proval for the "Sab­ga 1 Trinidad Tri­al" from the US FDA (Food and Drug Ad­min­is­tra­tion) and we have sub­mit­ted the pro­to­col to the ethics com­mit­tee lo­cal­ly for ap­proval. This study will on­ly be con­duct­ed in Trinidad and Ari­zona ini­tial­ly and will give our cit­i­zens the op­por­tu­ni­ty to ac­cess the lat­est ther­a­peu­tic agents for pan­cre­at­ic can­cer.

“We have a won­der­ful team of doc­tors on board this project who are ex­cit­ed to be in­volved in this in­ter­na­tion­al col­lab­o­ra­tion. They are Drs Olivia Dal­la Cos­ta, Ravi Ma­haraj, Karen Sealey, Kavi Capildeo, Dilip Dan, Vinay Minocha, Bri­an Ar­mour, Alexan­der Sinanan, Kel­lie Al­leyne Mike and Dy­lan Nar­i­nesingh.

Sab­ga, whose hus­band, John, passed away from the dis­ease on Jan­u­ary 26, 2017, and be­came the cat­a­lyst for her start­ing the foun­da­tion said the tri­al will be ex­pand­ed to more sites around the world once da­ta is col­lect­ed show­ing bet­ter out­comes for the pa­tient.

She said there had been no sig­nif­i­cant im­prove­ment in pan­cre­at­ic can­cer sur­vival rates for more than 40 years and the cur­rent drugs on­ly ex­tend­ed life by months.

Sab­ga said, there­fore, it was rec­om­mend­ed that even new­ly di­ag­nosed pa­tients go on a clin­i­cal tri­al as their first line of treat­ment. She said she was de­ter­mined to find that cure in John's name and was pas­sion­ate about bring­ing aware­ness and ed­u­ca­tion to the peo­ple whilst at the same time rais­ing mon­ey for re­search.

Sab­ga said hope must be cre­at­ed for the coun­try's fu­ture gen­er­a­tions.

UWI med stu­dents vol­un­teer with foun­da­tion

The JESF's op­er­a­tions con­sul­tant Lisa Ghany said af­ter see­ing the NGO's work at the St James Ra­dio­ther­a­py Cen­tre and at the Cau­ra Pal­lia­tive Hos­pi­tal, sev­er­al UWI first-year med­ical stu­dents ap­proached the foun­da­tion to do some hands-on work with pan­cre­at­ic can­cer pa­tients.

She said as part of the med­ical stu­dents' aca­d­e­m­ic cours­es they had to do a pro­gramme called the Pro­fes­sion­al­ism, Ethics and Com­mu­ni­ca­tion in Health mod­ule which re­quired do­ing prac­ti­cal hours in or­der to de­vel­op the skills in ethics and em­pa­thy need­ed to­wards pa­tients and their fam­i­lies.

The med­ical stu­dents are Tep­pa­ny Skin­ner, Jes­si­ca Las­tique, Amelia Rah­ming, Lean­ndra Man­gals­ingh, Sha­nia Saun­ders, Christi­na Dip­nar­ine and Farhaana Dan.

Christi­na Dip­nar­ine: I want­ed to study med­i­cine to find a cure for can­cer, which claimed my grand­moth­er

Christi­na Dip­nar­ine, 22 said her pas­sion was med­i­cine. She said she want­ed to study med­i­cine to help find a cure for the ter­ri­ble dis­ease can­cer, which claimed the life of her grand­moth­er as it had im­pact­ed her pro­found­ly.

Dip­nar­ine said can­cer was a slow and silent killer that crept up on peo­ple with­out warn­ing.

She said she would urge cit­i­zens to get reg­u­lar check-ups and take pre­ven­ta­tive mea­sures as pre­ven­tion is bet­ter than cure.

Dip­nar­ine said, un­for­tu­nate­ly, her grand­moth­er died from cer­vi­cal can­cer but was mis­di­ag­nosed by her doc­tor and treat­ed for the wrong dis­ease. She rec­om­mends get­ting sec­ond and even third opin­ions to re­duce the chances of mis­di­ag­no­sis. She said de­spite the heavy crit­i­cism faced, doc­tors in T&T worked tire­less­ly to pro­vide for their pa­tients. Her aim as a doc­tor is to have a gen­uine im­pact on her pa­tients.

Dip­nar­ine and her col­leagues were at the Green Mar­ket in San­ta Cruz re­cent­ly along with JESF founder Na­tal­ie Sab­ga to raise aware­ness and ed­u­cate peo­ple on pan­cre­at­ic can­cer.

Jes­si­ca Las­tique: Med Stu­dents will de­vel­op ethics, em­pa­thy, com­pas­sion

UWI first-year med­ical stu­dent Jes­si­ca Las­tique said the pur­pose of their practicum in the Pro­fes­sion­al­ism, Ethics and Com­mu­ni­ca­tion in Health course was to de­vel­op knowl­edge and skills with prac­ti­cal and re­al-world ex­po­sure to the con­cepts that they had been learn­ing in the­o­ry.

She said the goal was to pro­vide a ser­vice to the gen­er­al pub­lic, and in do­ing so they will gain an ap­pre­ci­a­tion for the val­ue of serv­ing so­ci­ety.

Las­tique said through this practicum they will prac­tice com­mu­ni­ca­tion skills, ethics, em­pa­thy, and pro­fes­sion­al­ism that were in­te­gral to their de­vel­op­ment as com­pas­sion­ate, eth­i­cal health­care pro­fes­sion­als in the vo­ca­tion of med­i­cine.

She said the stu­dents de­cid­ed to part­ner with the foun­da­tion be­cause they ap­pre­ci­at­ed the im­por­tance of the work it was do­ing to raise pub­lic aware­ness and ed­u­ca­tion on pan­cre­at­ic can­cer.

Las­tique said the stu­dents were par­tic­u­lar­ly drawn to this foun­da­tion by its in­volve­ment in pa­tient sup­port pro­grammes such as the Nurse Nav­i­ga­tor Ini­tia­tive that pro­vid­ed the much-need­ed emo­tion­al and per­son­al sup­port that can make a huge dif­fer­ence in pa­tients’ qual­i­ty of life.

She said in­ter­act­ing di­rect­ly with pa­tients and the wider com­mu­ni­ty to con­nect with those that had been af­fect­ed by pan­cre­at­ic can­cer gave them the op­por­tu­ni­ty to sup­port the work of the JESF while gain­ing in­valu­able ex­pe­ri­ence em­ploy­ing the lessons they had been taught thus far.

Badal: JESF funds pan­cre­at­ic can­cer pa­tients to ac­cess CCRI's Can­cer Nav­i­ga­tor Pro­gramme

Kim­ber­ly Badal, co-founder and ex­ec­u­tive di­rec­tor of the Caribbean Can­cer Re­search Ini­tia­tive (CCRI) said the John Sab­ga Foun­da­tion fund­ed pan­cre­at­ic can­cer pa­tients to ac­cess the CCRI's Can­cer Nav­i­ga­tor Pro­gramme.

She said through this pro­gramme, pa­tients were as­signed a nav­i­ga­tor whose role was to as­sess and ad­dress all bar­ri­ers to care or chal­lenges dur­ing the can­cer jour­ney.

Badal said CCRI's nav­i­ga­tors pro­vid­ed one-on-one sup­port, ed­u­ca­tion, and guid­ance while col­lect­ing da­ta for re­search.

She said since the pro­gramme was launched on No­vem­ber 10, 2018, five pan­cre­at­ic can­cer pa­tients had re­ceived 24 hours of per­son­alised nav­i­ga­tion time and care to date.

Peo­ple wish­ing to do­nate or vol­un­teer can do so through the foun­da­tion's web­site, www.johns­ab­ga.com or its Face­book page @ John Sab­ga Foun­da­tion or via phone 789-7930.


Related articles

Sponsored

Weather

PORT OF SPAIN WEATHER

Sponsored